Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma

American Journal of Pathology

Volumn 180, Issue 1, 2012, Pages 165-176

  Kitaba, Shun ^a   Murota, Hiroyuki ^a   Terao, Mika ^a   Azukizawa, Hiroaki ^a   Terabe, Fumitaka ^b   Shima, Yoshihito ^a   Fujimoto, Minoru ^b   Tanaka, Toshio ^a   Naka, Tetsuji ^b   Kishimoto, Tadamitsu ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; SODIUM CHLORIDE; TOCILIZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST; HARDNESS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KNOCKOUT MOUSE; LYMPH NODE; MAST CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; SKINFOLD THICKNESS;

ACTINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; BLEOMYCIN; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYSACCHARIDES, BACTERIAL; RECEPTORS, INTERLEUKIN-6; SCLERODERMA, LOCALIZED; SCLEROSIS; SKIN;

EID: 83455230778     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.09.013     Document Type: Article

References (35)

1. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis Rheum 23 1980 581 590
2. B.W. Needleman, F.M. Wigley, R.W. Stair Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma Arthritis Rheum 35 1992 67 72
3. M. Hebbar, J.M. Gillot, E. Hachulla, P. Lassalle, P.Y. Hatron, B. Devulder, A. Janin Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis Arthritis Rheum 39 1996 1161 1165 (Pubitemid 26240229)
4. M. Terao, H. Murota, S. Kitaba, I. Katayama Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma Exp Dermatol 19 2009 38 43
5. H. Murota, Y. Hamasaki, T. Nakashima, K. Yamamoto, I. Katayama, T. Matsuyama Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts Arthritis Rheum 48 2003 1117 1125 (Pubitemid 36418255)
6. E. Scala, S. Pallotta, A. Frezzolini, D. Abeni, C. Barbieri, F. Sampogna, O. De Pita, P. Puddu, R. Paganelli, G. Russo Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement Clin Exp Immunol 138 2004 540 546 (Pubitemid 39573637)
7. T. Yamamoto, S. Takagawa, I. Katayama, K. Yamazaki, Y. Hamazaki, H. Shinkai, K. Nishioka Animal model of sclerotic skin I: local injections of bleomycin induce sclerotic skin mimicking scleroderma J Invest Dermatol 112 1999 456 462 (Pubitemid 29171935)
8. T. Yamamoto, S. Takagawa, I. Katayama, K. Nishioka Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma Clin Immunol 92 1999 6 13 (Pubitemid 29315981)
9. M. Kuwana, T.A. Medsger Jr., T.M. Wright Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells J Immunol 164 2000 6138 6146 (Pubitemid 30408790)
10. T. Kishimoto The biology of interleukin-6 Blood 74 1989 1 10 (Pubitemid 19187402)
11. R.M. Gallucci, E.G. Lee, J.J. Tomasek IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice J Invest Dermatol 126 2006 561 568 (Pubitemid 43255642)
12. M.R. Duncan, B. Berman Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6 J Invest Dermatol 97 1991 686 692
13. Y. Kawaguchi, M. Hara, T.M. Wright Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A J Clin Invest 103 1999 1253 1260 (Pubitemid 29218295)
14. N. Nishimoto, T. Kishimoto Interleukin 6: from bench to bedside Nat Clin Pract Rheumatol 2 2006 619 626 (Pubitemid 44650950)
15. Y. Shima, Y. Kuwahara, H. Murota, M. Kawai, T. Hirano, J. Arimitsu, M. Narazaki, K. Hagihara, A. Ogata, I. Katayama, I. Kawase, T. Kishimoto, T. Tanaka The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab Rheumatology 49 2010 2408 2412
16. R.M. Gallucci, D.K. Sloan, J.M. Heck, A.R. Murray, S.J. O'Dell Interleukin 6 indirectly induces keratinocyte migration J Invest Dermatol 122 2004 764 772 (Pubitemid 38471347)
17. M. Kopf, H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, G. Kohler Impaired immune and acute-phase responses in interleukin-6-deficient mice Nature 368 1994 339 342 (Pubitemid 24104268)
18. N. Takagi, M. Mihara, Y. Moriya, N. Nishimoto, K. Yoshizaki, T. Kishimoto, Y. Takeda, Y. Ohsugi Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis Arthritis Rheum 41 1998 2117 2121 (Pubitemid 29009369)
19. Y. Kuwahara, Y. Shima, D. Shirayama, M. Kawai, K. Hagihara, T. Hirano, J. Arimitsu, A. Ogata, T. Tanaka, I. Kawase Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure Rheumatology (Oxford) 47 2008 1018 1024 (Pubitemid 351865926)
20. M. Hasegawa, S. Sato, H. Ihn, K. Takehara Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis Rheumatology (Oxford) 38 1999 612 617 (Pubitemid 29507328)
21. B. Crestani, N. Seta, M. De Bandt, P. Soler, C. Rolland, M. Dehoux, A. Boutten, M.C. Dombret, E. Palazzo, M.F. Kahn Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement Am J Respir Crit Care Med 149 1994 1260 1265 (Pubitemid 24147069)
22. E. Saito, M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T.F. Tedder, S. Sato CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse J Clin Invest 109 2002 1453 1462 (Pubitemid 34596171)
23. T. Matsushita, M. Hasegawa, K. Yanaba, M. Kodera, K. Takehara, S. Sato Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes Arthritis Rheum 54 2006 192 201 (Pubitemid 43122202)
24. H. Takemura, H. Suzuki, H. Fujisawa, T. Yuhara, T. Akama, K. Yamane, H. Kashiwagi Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor J Rheumatol 25 1998 1534 1539 (Pubitemid 28364759)
25. Y. Kawaguchi, E. Nishimagi, A. Tochimoto, M. Kawamoto, Y. Katsumata, M. Soejima, T. Kanno, N. Kamatani, M. Hara Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts Proc Natl Acad Sci U S A 103 2006 14501 14506 (Pubitemid 44484779)
26. C. Fukasawa, Y. Kawaguchi, M. Harigai, T. Sugiura, K. Takagi, M. Kawamoto, M. Hara, N. Kamatani Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts Eur J Immunol 33 2003 2792 2800 (Pubitemid 37337145)
27. T. Kadono, K. Kikuchi, H. Ihn, K. Takehara, K. Tamaki Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts J Rheumatol 25 1998 296 301 (Pubitemid 28088258)
28. A.E. Koch, L.B. Kronfeld-Harrington, Z. Szekanecz, M.M. Cho, G.K. Haines, L.A. Harlow, R.M. Strieter, S.L. Kunkel, M.C. Massa, W.G. Barr, S.A. Jimenez In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis Their role in early and late disease Pathobiology 61 1993 239 246 (Pubitemid 24007481)
29. T.A. Wynn Cellular and molecular mechanisms of fibrosis J Pathol 214 2008 199 210 (Pubitemid 351160157)
30. T.Z. Kirk, M.E. Mark, C.C. Chua, B.H. Chua, M.D. Mayes Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1 J Biol Chem 270 1995 3423 3428
31. E. Ofstad Scleroderma (progressive systemic sclerosis) A case involving polyneuritis and swelling of the lymph nodes Acta Rheumatol Scand 6 1960 65 75
32. M.L. Eloranta, K. Franck-Larsson, T. Lovgren, S. Kalamajski, A. Ronnblom, K. Rubin, G.V. Alm, L. Ronnblom Type I interferon system activation and association with disease manifestations in systemic sclerosis Ann Rheum Dis 69 2010 1396 1402
33. D. Kim, A. Peck, D. Santer, P. Patole, S.M. Schwartz, J.A. Molitor, F.C. Arnett, K.B. Elkon Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis Arthritis Rheum 58 2008 2163 2173 (Pubitemid 351988110)
34. M. Irla, N. Kupfer, T. Suter, R. Lissilaa, M. Benkhoucha, J. Skupsky, P.H. Lalive, A. Fontana, W. Reith, S. Hugues MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity J Exp Med 207 2010 1891 1905
35. M. Kuwana, T.A. Medsger Jr., T.M. Wright T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors J Clin Invest 96 1995 586 596